IP Library Assignment 045169/0549
Patent Assignment
Reel/Frame 045169/0549

Confirmatory License

Recorded: 2018-01-26 Pages: 2
Assignor
UNIVERSITY OF COLORADO
Executed: 2018-01-18
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property (1)
Humaneered Anti-Factor B Antibody
Patent: 7,964,705 →
Application: 12/049,233 →
Publication: US 2008/0299114
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 9, 2008
From: EMLEN, WOODRUFF; HOLERS, V. MICHAEL; FLYNN, PETER
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 021215/0595 →
Change of Name Dec 12, 2012
From: TALIGEN THERAPEUTICS, INC.
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029454/0515 →
Change of Address Feb 12, 2013
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029801/0586 →
Merger Jun 19, 2015
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 035866/0477 →